Senseonics (NYSE:SENS) announced today an underwritten offering of $50 million in 5.25% convertible senior notes due 2023, alongside a 30-day option for underwriters to buy up to an additional $7.5 million in notes to cover over-allotments.
The notes, which mature on Feb. 1, 2023, will be convertible into shares of Senseonics’ common stock at approximately $3.40 per share, the company reported.
Get the full story at our sister site, Drug Delivery Business News.
The post Senseonics prices $50m notes offering, touts Q4 and full-year prelims appeared first on MassDevice.
from MassDevice http://ift.tt/2BuEYjV
Cap comentari:
Publica un comentari a l'entrada